美国发现印度硬空囊生产商获得了补贴,导致了7.06%的关税;ITC在45天内作出损害决定. The U.S. found Indian hard empty capsule producers received subsidies, leading to a 7.06% duty; injury decision by ITC within 45 days.

美国商务部确定,印度硬空胶囊(包括ACG Associated Capsules)的生产商在2023年4月至2024年3月期间接受了可抵消的补贴,导致7.06%的反补贴税率。 The U.S. Department of Commerce has determined that Indian producers of hard empty capsules, including ACG Associated Capsules, received countervailable subsidies from April 2023 to March 2024, resulting in a 7.06% countervailing duty rate. 调查结果基于现场审查和利益攸关方的投入,涵盖了所有此类胶囊,不论其材料或形式如何。 The finding, based on on-site reviews and stakeholder input, covers all such capsules regardless of material or form. 现在案件转至美国国际贸易委员会,该委员会必须在45天内决定国内工业是否因这些进口商品而受到损害。 The case now moves to the U.S. International Trade Commission, which must decide within 45 days whether domestic industry is injured by these imports. 如果发现受伤,将征税,并恢复进口暂停;否则,案件结束和存款将被退还。 If injury is found, duties will be imposed and import suspensions reinstated; if not, the case ends and deposits will be refunded. 最后决定将于2025年12月29日生效。 The final determination is effective December 29, 2025.